TCR Ligand Discovery via T-Scan

Zhe Wang1, Genhong Cheng2, Guideng Li1

  • 1Center of Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China; Suzhou Institute of Systems Medicine, Suzhou 215123, China.

Trends in Immunology
|November 9, 2019
PubMed

Insights

Researchers developed a new screening platform for unbiased T cell receptor (TCR) ligand discovery. This method aids in identifying antigens that activate specific T cell responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biotechnology

Background:

  • T cell receptor (TCR) ligand discovery is essential for understanding T cell-mediated immunity.
  • Identifying antigens recognized by specific TCRs is critical for therapeutic and diagnostic applications.
  • Current methods for TCR ligand discovery can be limited in scope and efficiency.

Purpose of the Study:

  • To describe a novel functional T cell ligand screening platform.
  • To enable unbiased discovery of ligands for T cell receptors.
  • To facilitate the identification of antigens reactive against orphan TCRs.

Main Methods:

  • Development of a high-throughput screening platform utilizing functional T cell assays.
  • Application of the platform for unbiased screening of potential TCR ligands.
  • Validation of identified ligands for their ability to activate specific T cell responses.

Main Results:

  • Successful implementation of a functional T cell ligand screening platform.
  • Demonstration of the platform's capability for unbiased TCR ligand discovery.
  • Identification of novel antigens reactive against previously uncharacterized TCRs.

Conclusions:

  • The described platform offers a powerful tool for advancing TCR ligand discovery.
  • This approach can significantly accelerate the identification of T cell antigens.
  • The platform holds promise for applications in immunotherapy and diagnostics.

Related Concept Videos